NIH-funded research R01 grant

How bile acids affect insulin and metabolism in humans

Official title: Bile acid composition and insulin sensitivity

Funded at Columbia University Health Sciences · NIH-11391045 · Data updated 2026-11-12

A study using humanized mouse models and human cell systems will explore how a specific group of bile acids (12HBAs) influence insulin signaling and metabolic health in adults.

More Insulin Sensitivity research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 15, 2017
Project endAugust 31, 2027
Funding year2026
Award (this year)$640,435
NIH project number5R01DK115825-09
Project IDNIH-11391045 on NIH RePORTER

Who could benefit from this research

Could help

Adults with metabolic issues related to insulin resistance or metabolic syndrome could benefit from future therapies developed from these findings.

Less likely to help

Healthy individuals or those without metabolic concerns may not directly benefit from this research.

What this research studies

This project looks at how the composition of bile acids, especially 12HBAs, shapes glucose and lipid metabolism. Researchers will use humanized mice to mimic human bile acid profiles and study effects in liver, intestine, and fat tissue, plus ex vivo and cell-based experiments to pinpoint direct cellular actions. The goal is to uncover the mechanisms by which bile acid composition controls metabolic balance and to inform future therapies that lower harmful bile acid patterns. The work combines in vivo models with human-relevant systems to translate findings toward metabolic disease treatment.

Why it matters

Potential benefit: If successful, the work could lead to new approaches to treat metabolic diseases by targeting bile acid composition.

How similar studies have gone: Previous work shows that bile acid composition can influence metabolism, with translational models now allowing closer study of human-relevant mechanisms.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Haeusler, Rebecca Anne — Columbia University Health Sciences
  • Study coordinator: Haeusler, Rebecca Anne

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.